Literature DB >> 6631726

Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.

H Narita, T Nagao, H Yabana, I Yamaguchi.   

Abstract

We investigated the hypotensive and diuretic effects of diltiazem and hydralazine in conscious, spontaneously hypertensive rats (SHR) and their counterpart, Wistar Kyoto rats (WKY). Orally administered diltiazem induced dose-dependent hypotension both in SHR (10-60 mg/kg) and in WKY (30-100 mg/kg) and the effects were more pronounced in SHR than in WKY. Diltiazem did not cause tachycardia in either strain. Moreover, hypotensive doses of diltiazem acutely increased urinary excretion of sodium as well as urine volume in saline-loaded SHR and WKY. Chronic administration of diltiazem (30 mg/kg/day for 8 weeks) to young SHR caused no changes in body fluid distribution or in plasma sodium concentration. On the other hand, hydralazine not only showed almost the same hypotensive potency in SHR and WKY but also resulted reflex tachycardia in both strains. In addition, hydralazine (5 mg/kg) decreased urinary sodium excretion in saline-loaded SHR. In conclusion, it was suggested that diltiazem is an antihypertensive agent with an enhanced hypotensive action in the hypertensive state and without tachycardia and sodium retention effects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631726

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  In-vitro study of the effect of clentiazem on rabbit aorta and on myocardium.

Authors:  H Narita; R Ginsburg
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 2.  Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications.

Authors:  Swapnil Sonkusare; Philip T Palade; James D Marsh; Sabine Telemaque; Aleksandra Pesic; Nancy J Rusch
Journal:  Vascul Pharmacol       Date:  2006-01-20       Impact factor: 5.773

3.  Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel.

Authors:  Swapnil Sonkusare; Mony Fraer; James D Marsh; Nancy J Rusch
Journal:  Mol Interv       Date:  2006-12

4.  Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat.

Authors:  Bruno Igreja; Nuno Miguel Pires; Maria João Bonifácio; Ana Isabel Loureiro; Carlos Fernandes-Lopes; Lyndon Christopher Wright; Patrício Soares-da-Silva
Journal:  Hypertens Res       Date:  2014-10-09       Impact factor: 3.872

5.  Cardiovascular pharmacology of nicardipine in animals.

Authors:  T Takenaka; M Asano; K Shiono; M Shibasaki; O Inagaki
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits.

Authors:  R P Hof
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

7.  Basal and Activated Calcium Sensitization Mediated by RhoA/Rho Kinase Pathway in Rats with Genetic and Salt Hypertension.

Authors:  Michal Behuliak; Michal Bencze; Ivana Vaněčková; Jaroslav Kuneš; Josef Zicha
Journal:  Biomed Res Int       Date:  2017-01-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.